Concepedia

Publication | Open Access

Primary Renal Tumour Response in Patients Treated with Nivolumab and Ipilimumab for Metastatic Renal Cell Carcinoma: Real-world Data Assessment

DOIFull Paper Access

37

Citations

11

References

2022

Year

A. Meerveld-Eggink, Niels M. Graafland, Sofie Wilgenhof, Johannes V. van Thienen, Ferry Lalezari, Michael Grant, Bernadett Szabados, Yasmin Abu‐Ghanem, Teele Kuusk, Ekaterini Boleti,
European Urology Open Science

Abstract

Patients with metastatic kidney cancer receiving immunotherapy with nivolumab and ipilimumab had superior response at metastatic sites and better survival irrespective of International Metastatic RCC Database Consortium (IMDC) risk.

References

YearCitations

Page 1